cbdMD, Inc.
Close on Oct 19, 2026
- Market cap
- $3.70M
- P/E (TTM)
- –
- Dividend yield
- –
About cbdMD
Perfumes, Cosmetics & Other Toilet Preparations, SIC 2844
cbdMD, Inc. develops, manufactures, and markets natural wellness supplements and functional consumer products. The business offers broad-spectrum and full-spectrum hemp-derived cannabinoid items, including tinctures, gummies, capsules, and topicals under its core cbdMD label. It also provides pet supplements under Paw CBD, functional mushroom formulations through ATRX, and ready-to-drink cannabinoid beverages under the Herbal Oasis line. Its customer base includes individual consumers shopping online as well as business clients comprising regional retailers, specialty stores, and beverage wholesalers.
The enterprise is headquartered in Charlotte, North Carolina. It distributes merchandise throughout the United States via e-commerce and retail networks, with beverage availability across southeastern states such as North Carolina, Florida, Georgia, Alabama, Tennessee, and Texas. The firm sells through supermarket chains, specialty grocers, and alcohol retailers, and it reaches international markets by partnering with distributors in Central and South America.
Summary of the business section of cbdMD's latest annual report, written by StockData.
Company profile
Company
- Legal name
- cbdMD, Inc.
- Headquarters
- Charlotte, NC
- Address
- 8845 Red Oak Boulevard 28217
- Phone
- (704) 445-3060
- Website
- cbdmd.com
- Employees
- 42, Sep 30, 2025
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- Incorporated in
- North Carolina
- Fiscal year ends
- September 30
- Auditor
- Cherry Bekaert LLP, Charlotte, North Carolina
Stock & identifiers
- Ticker
- YCBD
- Exchange
- NYSE
- IPO date
- Sep 28, 2018
- Shares outstanding
- 11M, Aug 13, 2026
- Public float
- $1.64M, Mar 31, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-8 reverse, May 15, 2025; 1-for-8 reverse, May 7, 2025; 1-for-45 reverse, May 15, 2023; 1-for-45 reverse, Apr 25, 2023
- SEC CIK
- 1644903
- CUSIP
- 12482W408
- ISIN
- US12482W4087
- EIN
- 47-3414576
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Thomas Ronan Kennedy | CEO and CFO, Director | 513,722 |
| Scott G. Stephen | Director | 25,464 |
| William F. Raines III | Director | 2,293,758 |
| Sibyl Nichole Swift | Director | 4,145 |
| Kevin Charles Roe | Director | 26,707 |
| Bakari T. Sellers | Director | 4,324 |
| Jeffrey H. Porter | Director | 576,674 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2026 Kevin Mac Dermott | – | $300.00K | $207.31K | – | – |
| FY2026 Ronan Kennedy | $300.00K | $300.00K | $207.31K | – | – |
| FY2025 Kevin Mac Dermott | – | $275.01K | $181.38K | – | – |
| FY2025 Ronan Kennedy | $275.00K | $275.01K | $181.38K | – | – |
| FY2024 Kevin Mac Dermott | – | $384.64K | $191.44K | – | – |
| FY2024 Ronan Kennedy | $384.62K | $384.64K | $191.44K | – | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“At December 1, 2025 we had approximately 42 full-time employees and employ additional contractors to support the organization’s efforts.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 6, 2025 | Delisting | Notice of delisting from exchange (Form 25) |
| Jan 3, 2025 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Aug 30, 2024 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Aug 26, 2024 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jun 10, 2024 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Oct 11, 2019 | Listing | Registration of securities on an exchange (Form 8-A) |
| May 1, 2019 | Name change | Name changed from Level Brands, Inc. to cbdMD, Inc. |
| Dec 20, 2018 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 28, 2018 | IPO | Initial public offering priced (424B4 prospectus) |
| Nov 15, 2017 | Listing | Registration of securities on an exchange (Form 8-A) |
| Sep 27, 2016 | Name change | Name changed from LEVEL BEAUTY GROUP, INC. to Level Brands, Inc. |